Noll CF Tablets


Each NOLL CF tablet contains cefixime trihydrate IP (equivalent to anhydrous cefixime) 200mg and ofloxacin IP 200mg.


NOLL CF is the brand name for the antibiotic combination of cefixime, a third generation cephalosporin antibiotic and ofloxacin, a fluoroquinolones antibiotic. NOLL CF exhibits broad-spectrum activity, with a longer half-life and higher penetrability. This combination treats major bacterial infections such as ear-nose-throat infections, upper respiratory tract infections and genitourinary tract infections.

Cefixime is one of the very few antibiotics that are stable against cephalosporinase and beta-lactamase activity. Cefixime is the beta-lactam antibiotic that works by inhibiting the cell wall synthesis in the bacterial cells. This drug binds to specific penicillin-binding proteins (PBPs), which control the transpeptidation step of peptidoglycan synthesis. This binding between the PBPs and beta-lactam ring of cefixime prevents the cell wall synthesis, eventually leading to the bacterial cell death.

Ofloxacin is a synthetic antibiotic that belongs to the class of second-generation fluoroquinolones. It acts on the DNA gyrase and topoisomerase IV enzymes that are associated with the DNA replication in bacteria. By binding to these enzymes, ofloxacin hampers the unwinding and supercoiling properties of these enzymes and eventually arrest the cell growth in bacteria.


  • Bronchitis
  • Disseminated Gonococcal Infection
  • Pelvic Inflammatory disease
  • Prostatitis
  • Single Lesion Paucibacillary leprosy
  • Community-acquired pneumonia
  • Gonorrhea
  • Lyme disease
  • Otitis Media
  • Pharyngitis / Tonsillitis
  • Shigellosis
  • Typhoid Fever
  • Brucellosis
  • Gonococcal Urethritis / Cervicitis
  • Multibacillary Leprosy
  • Skin/ Skin Structure Infection
  • Otitis Externa
  • Urinary tract infections
  • Bacterial Sinusitis
  • Otitis Media

Dosage and Administration:

As directed by the physician


NOLL CF tablet is contraindicated in patients with hypersensitivity towards cefixime and ofloxacin. This medicine is also contraindicated in patients with epilepsy, Clostridium difficile infection, myasthenia gravis, renal insufficiency and seizures.

Adverse effects:

Adverse effects of this medicine include abdominal pain, nausea, vomiting, severe itching of skin, insomnia, dizziness, emesis, dyspepsia, headache, diarrhea, eosinophilia, hallucination and sinus tachycardia.


There are no sufficient and well-controlled studies when it comes to cefixime and ofloxacin administration in pregnant women and nursing mothers. Therefore, if you are pregnant or nursing, discuss with your doctor about your condition before taking this medicine.


NOLL CF tablets are available in 10X10’s Alu Alu packing.


The medical information on this website is provided as an information resource only. The information on this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider or a medical practitioner with any questions you may have regarding a medical condition, or to assist in understanding any information or in applying information, that you might have come across, on this website. Please note that it dangerous to take any medication without doctor’s prescription or professional advice from a registered health practitioner. Make sure to follow the instructions of physician/doctor/ registered medical practitioner before using this medicine. Medical and health information changes constantly. Therefore, the information provided on this website should not be considered current, complete or exhaustive. Please consult your healthcare provider, before coming to any conclusions with respect to your health condition or for guidance about a specific medical condition. The allopathic medicine as per the law in India must be sold by retail pharmacies holding valid trading drug license only.

Keep the medicines out of the children’s reach. This product is to be stored as recommended. Do not exceed the recommended dosage. Do not use this information in place of a visit, consultation or advice of your healthcare providers.